-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Precigen, Raises Price Target to $11

Benzinga·05/14/2026 14:15:42
Listen to the news
Citizens analyst Jason N. Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and raises the price target from $9 to $11.